---
document_datetime: 2025-08-21 15:07:44
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/fampyra-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: fampyra-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.4730121
conversion_datetime: 2025-12-26 20:26:47.660442
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Fampyra

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number      | Scope                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|-------------------------|-------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Marketing Authorisation | - Transfer of a marketing authorisation - | 10/07/2025                          | 06/08/2025                                  | SmPC,                            |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| Transfer - H / EMA/T/0000280278   | transfer of marketing authorisation from Acorda Therapeutics Ireland Limited to Merz Therapeutics GmbH   | Labelling and PL   |
|-----------------------------------|----------------------------------------------------------------------------------------------------------|--------------------|